Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|February 24, 2005
A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancerHenry Q Xiong, William Plunkett, Robert Wolff, et al.Cancer Research|March 18, 2004
Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activityDaoyan Wei, Liwei Wang, Yanjuan He, et al.International Journal of Cancer|November 26, 2003
NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cellsHenry Q Xiong, James L Abbruzzese, Edward Lin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Phase I and pharmacological study of oral 9-aminocamptothecin colloidal dispersion (NSC 603071) in patients with advanced solid tumorsHenry Q Xiong, Hai T Tran, Timothy L Madden, et al.Cancer Biology & Therapy|December 2, 2005
Prostaglandin E2 drives cyclooxygenase-2 expression via cyclic AMP response element activation in human pancreatic cancer cellsMaria S Pino, Steffan T Nawrocki, Francesco Cognetti, et al.Cancer|August 30, 2008
Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancerHenry Q Xiong, Gauri R Varadhachary, Joan C Blais, et al.Cancer Research|April 6, 2006
Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell linesMaria S Pino, Marissa Shrader, Cheryl H Baker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II TrialHenry Q Xiong, Arthur Rosenberg, Albert LoBuglio, et al.Oncogene|January 25, 2003
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasisDaoyan Wei, Xiangdong Le, Leizhen Zheng, et al.Journal of Pain and Symptom Management|May 22, 2007
Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiationCielito C Reyes-Gibby, Wenyaw Chan, James L Abbruzzese, et al.Pageof 3